Who Paid My Doc
A Prospective, Real-World, Interventional Study to Evaluate the Effect
Research payments
$1,612,586
Through program year 2025, $1,612,586 in research payments was reported against A Prospective, Real-World, Interventional Study to Evaluate the Effect, across 272 payments, paid by GlaxoSmithKline, LLC..
- Paid by
- GlaxoSmithKline, LLC.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,273,132 | 226 |
| 2024 | Research | $339,454 | 46 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Allen Silvey Barnegat, NJ Named on 25 payments
- Aaron Holley Washington, DC Named on 18 payments
- Robert Chrzanowski Columbus, GA Named on 16 payments
- Carlos Barrera Miami, FL Named on 15 payments
- Arjun Mohan Ann Arbor, MI Named on 12 payments
- Patricia Wade Hollywood, FL Named on 12 payments
- Arnold Kirshenbaum Bowie, MD Named on 10 payments
- Lisette Delgado Sanchez Naples, FL Named on 9 payments
- Brian Modena Solana Beach, CA Named on 8 payments
- Warren Abel Saint Petersburg, FL Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.